On July 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a new draft guidance that fills in critical operational details for the Inflation Reduction Act’s drug price negotiation program. The document explains how pharmaceutical manufacturers will be expected to implement Medicare’s negotiated prices when they go live in 2028, with specific expectations for both pharmacy-dispensed and physician-administered therapies. For life sciences companies, this guidan

Key Regulatory Proposals Aetna, a CVS Health company, has released the results of its second quarterly Provider Survey, highlighting a notable shift in the relationship between healthcare payers and providers. According to the data, the average provider trust score for payers has increased to 6.1, up from 5.4 in the first quarter of the year. Approximately 38% of survey participants now rate their payer partners an 8 or higher on a 10-point scale. Operational improvements app

The Centers for Medicare & Medicaid Services (CMS) has released a landmark proposed rule for Calendar Year 2027 that seeks to fundamentally alter the financial landscape of outpatient medicine. The proposal aims to curb federal and beneficiary spending by an estimated $5.7 billion by aggressively addressing payment disparities between Hospital Outpatient Departments (HOPDs) and independent medical settings. Key to this shift is the realignment of 340B drug payment rates to re

Optum Financial has completed the acquisition of Alegeus Technologies, adding a major benefits administration platform to its consumer finance business. Alegeus runs software that powers consumer‑directed healthcare accounts such as health savings accounts, flexible spending accounts, health reimbursement arrangements and COBRA coverage for millions of members. The deal fits within UnitedHealth Group’s broader push to deepen its presence in healthcare payments and benefit f

CVS Health has laid out a broad strategy to simplify how Americans use health insurance while tackling the rising cost of care and medicines. The company stated that it is focused on easing administrative burdens for clinicians, shifting payments toward value, and expanding the use of lower‑cost treatment options. Making utilization management less burdensome Aetna, the health insurance arm of CVS Health, reports that it now applies prior authorization requirements to fewer m

The Health and Human Services Department in the United States, administered by the Centers for Medicare & Medicaid Services (CMS), is...

More than 10 million individuals enrolled in Medicare Part D received no-cost vaccines in 2023 due to the Inflation Reduction Act, a...

CMS Unveils Further Instructions on Initiative Allowing Medicare Beneficiaries to Manage Prescription Drug Expenses via Monthly Payments....

CMS's Focuses on Sickle Cell Disease within the Cell and Gene Therapy Access Model The CMS declared that sickle cell disease (SCD) will...

November 21, 2023 Since the Opening of ACA Marketplace Coverage, 4.5 Million Selected Affordable Health Coverage Nearly 4.6 million...

October 03, 2023 All manufacturers of selected ten drugs agreed for price negotiation with CMS The Inflation Reduction Act, a...

September 23, 2023 CDC's ACIP endorsed Pfizer's RSV vaccine Pfizer is expanding its roster of recommended respiratory vaccines, endorsed...

The U.S. Food and Drug Administration (FDA) converted the approval of Leqembi (lecanemab) for treating Alzheimer's Disease from...

The Centers for Medicare & Medicaid Services provided new information on how individuals can obtain Medicare coverage for drugs that may...

CMS announced that the Inflation Reduction Act would reduce the cost of prescription drugs and premiums of healthcare plans CMS announced...

New payments terms announced for Medicare loans availed by providers The Centers for Medicare & Medicaid Services (CMS) announced amended...